Fresenius appoints Marc-Alexander Mahl to Management Board to oversee Kabi businesses

Bitget2026/10/15 16:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Fresenius appointed Marc-Alexander Mahl to its Management Board effective November 1, 2026, replacing Pierluigi Antonelli, who is leaving for personal reasons.
Mahl, head of Pharma and Nutrition since May 2023, will oversee Fresenius Kabi businesses.
CFO Sara Hennicken’s contract was extended for five years, through 2032.
Sébastien Guery, Nutrition head since April 2024, will lead the business as a standalone unit, reporting directly to Mahl.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2416814_en) on October 15, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Fresenius appoints Marc-Alexander Mahl to Management Board to oversee Kabi businesses

You may also like

Crypto prices